Patents by Inventor Pascal Torregrossa

Pascal Torregrossa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8048858
    Abstract: A peptide consisting of 5 to 30 amino acid residues, preferably 9 to 15, most preferably about 12 amino acid residues, comprising a B epitope of a poly-?2,8 sialic acid attached to NCAM which is recognized by an anti-poly-?2,8 sialic acid (PSA) antibody, the use thereof and the preparation of a medicament for modulating NCAM functions, to be administered for the prevention and/or the treatment of neurodegenerative diseases, brain and spine lesions, age-related learning and memory problems, and cancer is disclosed.
    Type: Grant
    Filed: July 18, 2008
    Date of Patent: November 1, 2011
    Assignees: Centre National de la Recherche Scientifique, Universite de la Mediterranee Aix-Marseilles 2, Schafer-N, Universitaetsklinikum Hamburg-Eppendorf
    Inventors: Genevieve Rougon, Pascal Torregrossa, Melitta Schachner, Claus Schafer Nielsen
  • Publication number: 20090105131
    Abstract: The invention relates to the use of a peptide consisting of 5 to 30 amino acid residues, preferably 9 to 15, most preferably about 12 amino acid residues, said peptide comprising a B epitope of a poly-?2,8 sialic acid attached to NCAM, which is recognized by an anti-poly-?2,8 sialic acid (PSA) antibody, for the preparation of a medicament for modulating NCAM functions, to be administered for the prevention and/or the treatment of neurodegenerative diseases, brain and spine lesions, age-related learning and memory problems, and cancer.
    Type: Application
    Filed: July 18, 2008
    Publication date: April 23, 2009
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE LA MEDITERRANEE AIX MARSEILLE II, SCHAFER-N, UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF
    Inventors: GENEVIEVE ROUGON, Pascal Torregrossa, Melitta Schachner, Claus Schafer Nielsen
  • Patent number: 7417025
    Abstract: The invention relates to the use of a peptide consisting of 5 to 30 amino acid residues, preferably 9 to 15, most preferably about 12 amino acid residues, said peptide comprising a B epitope of a poly-?2,8 sialic acid attached to NCAM, which is recognized by an anti-poly-?2,8 sialic acid (PSA) antibody, for the preparation of a medicament for modulating NCAM functions, to be administered for the prevention and/or the treatment of neurodegenerative diseases, brain and spine lesions, age-related learning and memory problems, and cancer.
    Type: Grant
    Filed: October 16, 2003
    Date of Patent: August 26, 2008
    Assignees: Centre National de la Recherche Scientifique, Universite de la Mediterranee AIX-Marseille, Schafer-N, Universitaetsklinikum Hamburg-Eppendorf
    Inventors: Geneviève Rougon, Pascal Torregrossa, Melitta Schachner, Claus Schafer Nielsen
  • Publication number: 20060122108
    Abstract: The invention relates to the use of a peptide consisting of 5 to 30 amino acid residues, preferably 9 to 15, most preferably about 12 amino acid residues, said peptide comprising a B epitope of a poly-?2,8 sialic acid attached to NCAM, which is recognized by an anti-poly-?2,8 sialic acid (PSA) antibody, for the preparation of a medicament for modulating NCAM functions, to be administered for the prevention and/or the treatment of neurodegenerative diseases, brain and spine lesions, age-related learning and memory problems, and cancer.
    Type: Application
    Filed: October 16, 2003
    Publication date: June 8, 2006
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Genevieve Rougon, Pascal Torregrossa, Melitta Schachner, Claus Schafer Nielsen